These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26866568)
21. The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report. Jeleń AM; Sałagacka A; Żebrowska MK; Mirowski M; Talarowska M; Gałecki P; Balcerczak EI Int J Med Sci; 2015; 12(12):974-9. PubMed ID: 26664259 [TBL] [Abstract][Full Text] [Related]
22. Deiodinases, organic anion transporter polypeptide polymorphisms and symptoms of anxiety and depression after ischemic stroke. Taroza S; Rastenytė D; Burkauskas J; Podlipskytė A; Kažukauskienė N; Patamsytė V; Mickuvienė N J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105040. PubMed ID: 32807452 [TBL] [Abstract][Full Text] [Related]
23. Effect of 3,5,3'-Triiodothyronine (T3) administration on dio1 gene expression and T3 metabolism in normal and type 1 deiodinase-deficient mice. Maia AL; Kieffer JD; Harney JW; Larsen PR Endocrinology; 1995 Nov; 136(11):4842-9. PubMed ID: 7588215 [TBL] [Abstract][Full Text] [Related]
24. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. Panicker V; Cluett C; Shields B; Murray A; Parnell KS; Perry JR; Weedon MN; Singleton A; Hernandez D; Evans J; Durant C; Ferrucci L; Melzer D; Saravanan P; Visser TJ; Ceresini G; Hattersley AT; Vaidya B; Dayan CM; Frayling TM J Clin Endocrinol Metab; 2008 Aug; 93(8):3075-81. PubMed ID: 18492748 [TBL] [Abstract][Full Text] [Related]
25. Expression levels of interferon-ɣ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders. Gałecka E; Talarowska M; Maes M; Su KP; Górski P; Kumor-Kisielewska A; Szemraj J Pharmacol Rep; 2018 Feb; 70(1):133-138. PubMed ID: 29367100 [TBL] [Abstract][Full Text] [Related]
26. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391 [TBL] [Abstract][Full Text] [Related]
27. Common genetic variations of deiodinase genes and prognosis of brain tumor patients. Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060 [TBL] [Abstract][Full Text] [Related]
28. Single Nucleotide Polymorphisms in Thyroid Hormone Transporter Genes MCT8, MCT10 and Deiodinase DIO2 Contribute to Inter-Individual Variance of Executive Functions and Personality Traits. Uter JC; Krämer UM; Schöls L; Rodriguez-Fornells A; Göbel A; Heldmann M; Lichtner P; Brabant G; Münte TF Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):573-581. PubMed ID: 31820424 [TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment in remitted and non-remitted depressive patients: A follow-up comparison between first and recurrent episodes. Roca M; López-Navarro E; Monzón S; Vives M; García-Toro M; García-Campayo J; Harrison J; Gili M Eur Neuropsychopharmacol; 2015 Nov; 25(11):1991-8. PubMed ID: 26293584 [TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder. Gałecki P; Szemraj J; Bartosz G; Bieńkiewicz M; Gałecka E; Florkowski A; Lewiński A; Karbownik-Lewińska M J Pineal Res; 2010 May; 48(4):311-7. PubMed ID: 20433639 [TBL] [Abstract][Full Text] [Related]
31. [Differences in cognitive functioning of men and women with a diagnosis of depression]. Fitas A; Berent D; Talarowska M Pol Merkur Lekarski; 2010 Mar; 28(165):199-202. PubMed ID: 20815167 [TBL] [Abstract][Full Text] [Related]
32. COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder. Gałecki P; Talarowska M; Bobińska K; Szemraj J Psychiatry Res; 2014 Feb; 215(2):488-90. PubMed ID: 24388097 [TBL] [Abstract][Full Text] [Related]
33. Human Type 1 Iodothyronine Deiodinase ( França MM; German A; Fernandes GW; Liao XH; Bianco AC; Refetoff S; Dumitrescu AM Thyroid; 2021 Feb; 31(2):202-207. PubMed ID: 32718224 [No Abstract] [Full Text] [Related]
34. Chemokine (C-C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder. Małujło-Balcerska E; Kumor-Kisielewska A; Szemraj J; Pietras T Pharmacol Rep; 2022 Aug; 74(4):759-768. PubMed ID: 35294735 [TBL] [Abstract][Full Text] [Related]
35. Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment. Luo M; Zhou XH; Zou T; Keyim K; Dong LM Genet Mol Res; 2015 May; 14(2):5407-16. PubMed ID: 26125736 [TBL] [Abstract][Full Text] [Related]
36. Is there a link between TNF gene expression and cognitive deficits in depression? Bobińska K; Gałecka E; Szemraj J; Gałecki P; Talarowska M Acta Biochim Pol; 2017; 64(1):65-73. PubMed ID: 27991935 [TBL] [Abstract][Full Text] [Related]
37. Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Bobińska K; Kowalczyk E Neurochem Res; 2012 Aug; 37(8):1761-7. PubMed ID: 22562440 [TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders. Galecki P; Szemraj J; Florkowski A; Talarowska M; Bienkiewicz M; Galecka E; Lewinski A Neuro Endocrinol Lett; 2010; 31(1):97-102. PubMed ID: 20150879 [TBL] [Abstract][Full Text] [Related]
39. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
40. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Peeters RP; van den Beld AW; Attalki H; Toor Hv; de Rijke YB; Kuiper GG; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E75-81. PubMed ID: 15727947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]